login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
COMPASS THERAPEUTICS INC (CMPX) Stock News
USA
- NASDAQ:CMPX -
US20454B1044
-
Common Stock
3.78
USD
-0.32 (-7.8%)
Last: 10/29/2025, 8:21:03 PM
3.8787
USD
+0.1 (+2.61%)
After Hours:
10/29/2025, 8:21:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CMPX Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Compass Therapeutics
Compass Therapeutics to Participate in Upcoming September Investor Events
3 months ago - By: Compass Therapeutics
Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
3 months ago - By: Compass Therapeutics
Compass Therapeutics Announces Proposed Public Offering
3 months ago - By: The Motley Fool
Compass Therapeutics Posts Wider Q2 Loss
3 months ago - By: Compass Therapeutics
Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update
3 months ago - By: Benzinga
- Mentions:
SPHR
ARQ
DOLE
TELA
...
Earnings Scheduled For August 11, 2025
3 months ago - By: Compass Therapeutics
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
a year ago - By: BusinessInsider
CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024
a year ago - By: InvestorPlace
CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024
3 months ago - By: Yahoo Finance
- Mentions:
COMP
Compass Therapeutics (CMPX) Gains Analyst Confidence with Promising Cancer Pipeline
6 months ago - By: Compass Therapeutics
Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update
6 months ago - By: Compass Therapeutics
Compass Therapeutics to Participate in Upcoming May Investor Events
6 months ago - By: Compass Therapeutics
Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
6 months ago - By: Compass Therapeutics
Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
7 months ago - By: Compass Therapeutics
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
7 months ago - By: Benzinga
Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer
8 months ago - By: Compass Therapeutics
Compass Therapeutics Reports 2024 Financial Results and Provides Corporate Update
a year ago - By: Compass Therapeutics
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
a year ago - By: Compass Therapeutics
Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
a year ago - By: Compass Therapeutics
Compass Therapeutics to Participate in Upcoming Investor Events
a year ago - By: Compass Therapeutics
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
a year ago - By: Compass Therapeutics
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
a year ago - By: Compass Therapeutics
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
a year ago - By: Compass Therapeutics
Compass Therapeutics to Participate in Upcoming Investor Events
a year ago - By: Compass Therapeutics
Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
a year ago - By: Compass Therapeutics
Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference
a year ago - By: Compass Therapeutics
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
a year ago - By: Compass Therapeutics
Compass Therapeutics Announces CEO Transition
Please enable JavaScript to continue using this application.